RLMD · Forms 3, 4, 5
Insider trades at RELMADA THERAPEUTICS, INC.
2 insiders bought $1.7M of RELMADA THERAPEUTICS, INC. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for RELMADA THERAPEUTICS, INC. (RLMD) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Maged Shenouda | Chief Financial Officer | Buy | 79,800 | $4.25 | $339K | Form 4 | |
| Sergio Traversa | Chief Executive Officer | Buy | 100,000 | $4.10 | $410K | Form 4 | |
| Maged Shenouda | Chief Financial Officer | Buy | 120,200 | $4.20 | $505K | Form 4 | |
| Sergio Traversa | Chief Executive Officer | Buy | 100,000 | $4.18 | $418K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.